Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis

NCT02643212 is registered in ClinicalTrials.gov with David Garcia Cinca as lead sponsor.

NCT NCT02643212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02643212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis
Lead sponsor
David Garcia Cinca
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2016
Completion date
December 31, 2019
Enrollment
160 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis